Why Australians self-medicate with cannabis against medical advice

This Australian study reveals how adults are actually using cannabis in practice, uncovering a significant gap between usage patterns and medical evidence. Among 3,042 respondents, only 1.9% used cannabis exclusively for medical purposes, while 6.7% used it recreationally only, and 5.0% engaged in dual-use (combining medical and recreational purposes). The most commonly treated conditions were anxiety (64%), pain (53%), and depression (52%)—notably, conditions for which medical guidelines emphasize that cannabis evidence remains limited. This disconnect suggests many Australians are self-medicating with cannabis for conditions without strong scientific backing, despite Australia's increasingly commercialized medicinal cannabis framework.

The research identified important demographic patterns in how different groups use cannabis. Older adults (56+ years) were 3.5 times more likely to use cannabis for pain compared to younger users, while females were 2.3 times more likely to report using it for anxiety than males. Interestingly, dual-use patients (those mixing medical and recreational consumption) showed higher rates of using cannabis for sleep, depression, and post-traumatic stress disorder compared to medical-only users, suggesting these conditions may be particularly driven by self-perceived therapeutic benefit rather than prescribed treatment.

The findings highlight a critical regulatory and educational challenge for Australia. While medicinal cannabis frameworks aim to provide evidence-based treatment options, the data shows that cannabis is predominantly being used for conditions—particularly anxiety and depression—where clinical guidance remains cautious due to insufficient high-quality evidence. This underscores the urgent need for clearer public health messaging, better prescribing guidelines, and more rigorous clinical research to match the reality of how Australians are actually using cannabis.